AI Meets the Mind: How Health Data Science Is Rewiring Neuroscience and Psychology

Artificial intelligence is quietly transforming two of the most intimate fields of medicine: neuroscience and psychology. A new editorial published in Frontiers in Computational Neuroscience by Lei Lu of King’s College London, Zhiqiang Huo of Queen Mary University of London, Jin Li of Nanjing University of Information Science and Technology, and Erying Zhao of Harbin Medical University surveys a Research Topic dedicated to health data science and AI in neuroscience and psychology, and the picture that emerges is one of remarkable promise shadowed by stubborn technical obstacles. The collection spans deep learning applied to adolescent brain imaging, reinforcement learning simulations of depression, AI screening for body dysmorphic disorder, laser-based gesture recognition for rehabilitation, and a comprehensive review of AI models in neurodegenerative disease. Together, these studies illustrate how machine intelligence can integrate functional, biological, clinical, and behavioral data to yield insights that conventional analytical approaches struggle to reach.

The central challenge, the editors argue, is not a shortage of data but the character of the data themselves. Neuroscience and psychology datasets are frequently noisy, heterogeneous, and unevenly labeled, which complicates model development, result interpretation, and ultimately clinical translation. A single brain imaging study may combine functional MRI sequences collected under different protocols, self-report questionnaires with inconsistent response scales, and clinical records riddled with missing entries. Measurement noise alone has been shown to limit the accuracy of brain-behavior predictions, a point underscored by a 2024 Nature Communications analysis cited in the editorial. Any AI system hoping to move from the laboratory to the clinic must therefore be robust, interpretable, and generalizable across diverse populations and real-world settings, not merely accurate on a curated benchmark.

One of the most striking contributions comes from Gao and colleagues, who developed a deep learning framework for health risk assessment in adolescents. Their architecture combines a two-dimensional convolutional autoencoder with multi-sequence learning and multi-scale asynchronous correlation information extraction, a mouthful of terminology that describes a genuinely clever engineering solution. Applied to functional MRI data from the Adolescent Risk Behavior dataset, the framework was designed to capture both spatial relationships among brain regions and time-shifted correlations between them, all while contending with limited labeled data, a chronic constraint in psychiatric research. The study demonstrated promising performance in understanding and predicting health-related risks in adolescents, suggesting that deep learning could enhance the precision of health risk assessment and support early identification of individuals who may benefit from timely intervention. The editors caution, however, that more robust external validation and assessment of generalizability across diverse populations are essential before such tools are ready for real-world implementation.

Perhaps the most conceptually ambitious study in the collection, from Chalmers and colleagues, used deep reinforcement learning to simulate the effect of dendritic spine loss as observed in major depressive disorder. Dendritic spines are the tiny protrusions on neurons that receive synaptic inputs, and their loss is a well-documented histopathological correlate of depression. When the researchers simulated this spine loss in an artificially intelligent agent, the agent produced a variety of MDD-like behaviors, including anhedonia, increased temporal discounting, avoidance, and an altered exploration-exploitation balance. Remarkably, simulating alternative and longstanding reward-processing-centric conceptions of MDD, such as dysfunction of the dopamine system, altered reward discounting, context-dependent learning rates, and increased exploration, did not produce the same range of depressive behaviors. This differential result positions AI not merely as a diagnostic or predictive instrument but as a computational microscope for probing pathophysiology, offering a way to test mechanistic hypotheses about depression that would be impossible to isolate experimentally in human patients, and potentially informing therapeutic strategies.

Clinical sensitivity is also the theme of a perspective contributed by Haykal and Kroumpouzos, who examined the opportunities, limitations, and ethical considerations of leveraging AI to detect body dysmorphic disorder. BDD is a frequently overlooked yet clinically significant condition characterized by a persistent and intrusive preoccupation with perceived flaws in appearance, flaws that are typically minor or imperceptible to others. Individuals with BDD often seek repeated cosmetic procedures in hopes of achieving relief, but they typically find little psychological benefit from such interventions, making early recognition a genuine clinical priority. The authors explored how AI approaches could improve the management of BDD through early diagnosis, prompt reflection, highlighting of concerning patterns, and enhanced clinical sensitivity, while insisting on transparency, empathy, and restraint in how such systems are deployed with a vulnerable patient population.

Rehabilitation technology represents another frontier where AI and computational neuroscience converge, particularly for older adults. Xing and colleagues developed a deep learning model to process point-cloud data acquired from laser sensors for non-contact analysis of hand gestures and surface features, with the aim of supporting hand function rehabilitation through human-machine interaction. By analyzing hand surface point clouds with local feature extraction and abstraction and enhancement of dimensional information, the approach effectively captured relevant spatial information and demonstrated promising performance in gesture and hand-surface feature recognition. The significance of non-contact sensing should not be understated: cameras and laser scanners can monitor movement without wearable electrodes or markers, making rehabilitation assessment more natural, accessible, and data-driven, especially for patients who find conventional instrumentation uncomfortable or stigmatizing.

At the scale of entire disease categories, Liu and colleagues reviewed the application of AI-based radiogenomics in managing neurodegenerative diseases, including multiple sclerosis, dementia, Parkinson’s disease, amyotrophic lateral sclerosis, and Creutzfeldt-Jakob disease. Radiogenomics, the fusion of imaging-derived radiomic features with genomic data, allows computational models to link visible brain changes with molecular signatures. The review summarized representative AI models across these conditions and catalogued publicly available data resources supporting radiomics, genomics, and radiogenomics studies. It also highlighted key directions for future research, including strategies to mitigate overfitting in high-dimensional genomic data, robust validation approaches that account for modality-specific variability and incomplete data, and efforts to bridge the gap between AI-enhanced models and their translation into real-world clinical practice, a gap that has swallowed many otherwise impressive algorithms.

Looking forward, the editors identify emerging methodologies that extend beyond what the Research Topic has demonstrated. Large language models may enable more sophisticated analysis and interpretation of complex medical information, supporting personalized risk assessment and tailored intervention, with recent work on knowledge-augmented models using verified retrieval for improved medical reasoning cited as an example. Multimodal learning could integrate complementary data sources to generate more comprehensive representations of individual health, and integrating subjective measurements such as questionnaires with objective measurements such as wearable sensing data may further enhance the understanding of individual health status. Further advances in model optimization, robustness, interpretability, and clinical validation will be essential for translating these innovations into real-world applications, and the editors point to automated architecture search and layer-wise convex network designs for physiological signal classification as evidence that optimization methods are maturing rapidly.

What makes this editorial more than a routine literature survey is its insistence on interdisciplinary synergy as the decisive factor. The editors argue that progress will depend on collaboration across neuroscience, psychology, clinical medicine, and computational sciences, developing AI systems that are technically capable, clinically meaningful, and generalizable across diverse populations and settings. The studies collected here, from simulated dendritic spines to laser-scanned hand gestures, show that the field has moved well beyond proof-of-concept demonstrations. The remaining distance to responsible clinical translation is not primarily a matter of algorithmic sophistication but of validation, ethics, and deployment, and the editors hope this Research Topic will stimulate further interdisciplinary research and responsible translation of health data science and AI in neuroscience and psychology, fields where the stakes, quite literally, include the human mind itself.

Subject of Research: Health data science and artificial intelligence applications in neuroscience and psychology

Article Title: Editorial: Health data science and AI in neuroscience & psychology

Article References: Lu, L., Huo, Z., Li, J., & Zhao, E. (2026). Editorial: Health data science and AI in neuroscience & psychology. Frontiers in Computational Neuroscience, 20, Article 2002192. https://doi.org/10.3389/fncom.2026.2002192

Image Credits: AI Generated

DOI: 10.3389/fncom.2026.2002192

Keywords: artificial intelligence, health data science, neuroscience, psychology, deep learning, major depressive disorder, body dysmorphic disorder, rehabilitation, radiogenomics, neurodegenerative diseases, fMRI, machine learning